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Background: Asthma is the result of a complex interaction between environmental factors and genetic variants
that confer susceptibility. The glutathione S-transferases (GSTT1 and GSTM1) are phase II enzymes thought to protect
the airways from oxidative stress. Few and contradictory data are available on the association between asthma
development and GSTT1 and GSTM1 polymorphisms in different ethnic groups. The current study aimed to investigate
whether these polymorphisms are associated with asthma development in the Egyptian population.
Methods: The cross-sectional study was performed on 94 asthmatic children 6 -12 yrs and 90 matched healthy
controls. Candidates were subjected to clinical evaluation and measurement of absolute blood eosinophilic count, total
serum IgE, and GSTT1 and GSTM1 genotype by multiplex PCR technique.
Results: The results for GSTT1 null genotype were 87.2% and 97.2% for asthmatic children and controls respectively and
showed to be significantly more in controls (P =0.007, OR:0.683, CI: 0.034 -0.715). The results for GSTM1 null genotype
were 50% and 61.1% for asthmatic children and controls respectively and showed to be nonsignificant (p = 0.130, OR:
1.000, CI: 0.54- 1.86). Also, no association was detected between GSTT1 and GSTM1 polymorphisms and atopic conditions
or asthma severity.
Conclusion: The significant detection of GSTT1 null genotype more in controls than in asthmatics with no association
with other atopic manifestations or asthma severity and the lack of association detected between GSTM1 polymorphism
in relation to asthma, atopy or asthma severity confirm the uncertain role of those genes in the development of asthma.
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Asthma is a disorder of the airways characterized by sev-
eral symptoms such as airflow obstruction, airway in-
flammation, and hyper responsiveness [1]. The study of
genetic factors involved in complex pathologies such as
asthma is arduous, not only because of human genetic
variability, or incomplete penetrance, but also because,
in complex disease studies, the importance and strength
of gene to gene and gene to environment interactions
need to be considered [2]. The prevalence of candidate
gene polymorphisms for asthma varies considerably world-
wide, and accordingly, ethnicity should be considered as a* Correspondence: nihal-r@hotmail.com
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unless otherwise stated.factor that might act on and influence asthma develop-
ment. Previous data based on intra- and inter-population
frequency differences suggest that the association between
a given genetic polymorphism and asthma cannot be ex-
trapolated from one ethnic group to another [3].
Phase II detoxification enzymes, particularly classes of
GSTs, play an important role in inflammatory responses
triggered by xenobiotic or reactive oxygen compounds
[4]. The GSTM1 and GSTT1 are two important phase II
enzymes that protect the airways from oxidative stress
[5]. They utilize as substrates a wide variety of products
of oxidative stress [6]. The inability of GST variant en-
zymes to detoxify reactive oxygen species contributes to
the activation of the inflammatory process, bronchocon-
striction, and the exacerbation of asthma symptoms [4].
In particular, GSTM1 and GSTT1 null polymorphismsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Numerous studies have documented associations between
genes implicated in the oxidative stress response and re-
spiratory phenotypes, but data suggest that they may not
be consistent across ethnic groups owing to differences in
intra- and inter-ethnic allele frequencies [7].
The aim of the current study was to detect the presence
of an association between GSTM1 and GSTT1 polymor-
phisms and asthma, atopy or asthma severity.
Methods
The present cross-sectional case–control study is con-
ducted on a group of Egyptian asthmatic children (n: 94)
and their age and sex matched healthy controls (n: 90)
from September 2012 to June 2013. Patients were re-
cruited from the allergy clinic of Cairo university spe-
cialized pediatric hospital where they were following up
after being diagnosed according to GINA guidelines cri-
teria of asthma classification [8]. All patients were sub-
jected to a questionnaire containing a detailed history
and clinical examination with emphasis on age, sex, fam-
ily history, presence of atopic manifestations and asthma
severity classification according to GINA Guidelines [8].
The following investigations were performed for all pa-
tients and controls.
Total immunoglobulin E (IgE) and Prick test assays
Atopy was defined by a positive history of atopic manifes-
tations, positive skin prick test (wheal diameter ≥3 mm) to
at least one of the following aeroallergens (Dermatopha-
goides Farinae, hay Dust, Dermato-pteronyssinus, Alter-
naria Tenuis, Moulds II, Candida Albicans, Cat epithelia,
Hen’s egg, Dog epithelia, Grasses/cereals, Cow’s milk in
the presence of positive histamine control and negative
physiological saline control using reagents obtained from
Allergopharma D21462 Reinbek, Germany) and by the
quantitative determination of human total IgE in serum
using the DiaMed Eurogen IgE quantitative technique
which is a monoclonal antibody based enzyme immuno-
assay (Positive values were taken to be ≥200 IU/ml). Among
the 94 asthmatic children there were 67 atopic and 27 non-
atopic children.
Pulmonary function tests assay
Spirometric measurements using a Jaeger Master Screen
Spirometry system (Jaeger Co) were done and included
forced vital capacity (FVC), forced expiratory volume in
1 s (FEV1), and forced expiratory flow between 25% and
75% expired volume (FEF25-75). Short-acting broncho-
dilators were stopped at least 8 h before the test. All pul-
monary function data were collected at a single visit. A
minimum of 3 results within 10% of each other were re-
corded, and the result with the highest FEV1 was ana-
lyzed. The participants were not suffering from asthmaexacerbations or other acute illnesses at the time of the
measurement of pulmonary function. The lung func-
tion test results were expressed as a percentage of that
predicted.
The personal, family, medical history and clinical pres-
entation of controls were free of any atopic or allergic
diseases with negative skin prick tests, normal total IgE
values, normal lung function tests.
Genotyping of GSTT1 and GSTM1
100 ng of DNA were amplified in a-50 ul multiplex reac-
tion mixture containing 0.90 pmol of each of the follow-
ing GSTT1 primers (GSTT1-Forward: GAACTCCCTG
AAAAGCTAAAGC and GSTT1-Reverse: GTTGGGCT
CAAATATACGGTGG) and GSTM1 primers (GSTM1-
Forward: TTCCTCACTGGTCCTCACATCTC and GST
M1-Reverse: TCACCGGATCATGGCCAGCA). As an
internal control, the beta-globulin gene was also amplified
using the following amplification sequence (Forward pri-
mer: GCCCTCTGCTAACAAGTCCTAC and Reverse
primer: GCCCTAAAAAGAAAATCGCCAATC) [9]. The
amplification reaction consisted of 0.9 pmol of each pri-
mer added to 12.5 u PCR master mix which contains
3.5 mM MgCl2, 200 uM dNTPs, 5 ul 10X PCR buffer, and
2U TaqDNA polymerase (Fermentas).
The PCR protocol included: initial melting temperature
of 94°C (5 minutes), amplification by 35 cycles of 20 sec-
onds at 94°C, 20 seconds at 64°C, and 30 second at 72°C)
then final extension at 72°C for 7 minutes. Analysis of
PCR products on agarose gels where a fragment of 215 pb
indicated the presence of GSTM1, a fragment of 480 pb
indicated the presence of GSTT1 and a fragment of 280
pb indicated the positive internal control B globulin. The
subjects were classified as either (+), when at least one
specimen of the gene was detected, or (−) when they
showed a null genotype.
Ethical considerations
The aim and nature of the study was explained for each
candidate and/or parent before inclusion. An informed
written consent was obtained from parents/surrogates be-
fore enrollment. Children old enough were asked for con-
sent. Cairo University Hospital Research Ethical Committee
approved the work and it conforms to the provisions of the
Declaration of Helsinki in 1995 (as revised in Seoul 2008).
Statistical analysis
Data were statistically described in terms of mean ± stand-
ard deviation (± SD), median and range, or frequencies
(number of cases) and percentages when appropriate. Com-
parison of numerical variables between the study groups
was done using Student’s t test for independent samples
when comparing 2 groups of normally distributed data and
Mann Whitney test when comparing 2 groups of non-
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group comparisons was used to compare numerical data
between more than 2 groups. For comparing categorical
data, Chi square (χ2) test was performed. Exact test was
used instead when the expected frequency is less than 5.
Odds ratio with its 95% CI was used to present the relation
between haplotypes in cases and controls. Haldane modifi-
cation was used when the occurrence of any haplotypes
was zero. p values less than 0.05 was considered statistically
significant. All statistical calculations were done using
computer programs SPSS (Statistical Package for the
Social Science; SPSS Inc., Chicago, IL, USA) version 15
for Microsoft Windows.
Results
We investigated 94 children with asthma, approximately
67% of whom were atopic, and 90 age and sex matched
healthy controls. Table 1 summarizes the characteristics
of both groups. Age was found to be significantly higher
in controls (p = 0.025). Male sex was found to be signifi-
cantly higher in asthmatics (p = 0.019). No significant
differences were found between asthmatic patients and
healthy controls for any of the other characteristics ana-
lyzed. Data regarding the genotype frequencies of theTable 1 Characteristics and genotype distributions in asthma
Asthmatics Controls
Age (Mean ± SD), years 7.65 ± 1.916 8.27 ± 1.
Sex
Male 62 (66%) 44 (48.9%
Female 32 (34%) 46 (51.1%
Spirometry
FEV1 (%predicted)** 97 ± 6.2 _
FVC (%predicted)*** 96 ± 8.2
Disease severity
Mild persistent 21 (22%) _
Moderate persistent 36 (38.3%)
Severe persistent 37 (39.3%)
Atopy
Atopic 67 (71.3%)
Non atopic 27 (28.7%) 90 (100%
Passive smoking exposure 39 (41.5%) 28 (31.1%
GSTT1
Null 82 (87.2% 88 (97.8%
Present 12 (12.8%) 2 (2.2%)
GSTM1
Null 47 (50%) 55 (61.1%
Present 47 (50%) 35 (38.9%
ªData are expressed as no. (%) of patients unless otherwise indicated.
*P-value less than 0.05 is considered statistically significant.
**FEV1: forced expiratory volume in 1 second, ***FVC: forced vital capacity.GSTT1 and GSTM1 homozygous deletions in asthmatics
and controls are also shown in Table 1. GSTT1 null geno-
type was found to be significantly higher in controls than in
asthmatics (p = 0.007, CI = 0.683, OR = 0.034-0.714). No
significant difference in the genotype distribution of the
GSTM1 gene was found between asthmatics and controls.
No significant differences in the genotype distributions of
the GSTT1 or GSTM1 genes were found between atopic
and nonatopic asthmatics (p = 0.706 and 0.820 respectively)
as shown in Table 2. Also, no significant differences in the
genotype distributions of the GSTT1 or GSTM1 genes
were found between asthmatics stratified by disease severity
(p = 0.236 and 0.892 respectively) as shown in Table 3.
Discussion
It was recently recognized that GSTs play an active role
in oxidative defenses and members of this superfamily
may be determinants of respiratory health [10]. The
presence of the GSTT1 null polymorphism was 87.2%
and 97.2% in asthmatics and controls respectively and
the results showed to be significantly higher in controls
(P = 0.007, OR:0.683, CI: 0.034 -0.715). The results for
GSTM1 were 50% and 61.1% respectively and showed to
be nonsignificant (p = 0.130, OR: 1.000, CI: 0.54- 1.86).tics and controlsª
P-value OR 95% CI












) 0.130 1.000 0.539-1.857
Table 2 Genotype distributions in atopic asthmatics and
non-atopic asthmaticsª
Atopic asthmatics Non-atopic asthmatics P-value
n = 67 (%) n = 27 (%)
GSTT1
Null 59 (88.1%) 23 (85.2%)
Present 8 (11.9%) 4 (14.8%) 0.706
GSTM1
Null 33 (49.3%) 14 (51.9%)
Present 34 (50.7%) 13 (48.1%) 0.820
ªData are expressed as no. (%) of patients unless otherwise indicated.
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GST genes on asthma demonstrated that a large Avon
Longitudinal Study of Parents and Children found a
protective effect on asthma of the GSTT1 null allele
in mothers (OR: 0.71; 95% CI: 0.57–0.90 and 0.84;
0.63–1.12, for heterozygotes and null homozygotes, re-
spectively, compared with wild-type homozygotes) and
children (0.91; 0.76–1.11 and 0.89; 0.70–1.13) [11]. No
association of the disease with GSTT1 null genotype
was noted by several studies in different populations
[2,12-20]. However, in contrary to our findings an in-
creased risk was seen in individuals with this genotype
in some studies [3,21-24]. Similarly, a study performed
on Egyptian population in Zagazig -located in northern
Egypt- showed that asthmatic children had a significant
lower prevalence of GSTT1 null genotype than the con-
trol group (P = 0.003). However, a higher prevalence of
the GSTM1 null genotype was observed in the asthmatic
group [25]. As our study was performed in Cairo- the
capital of Egypt located in the centre- the enrolled patients
were referred from upper Egypt that’s why a difference in
GSTM1 null genotype frequencies among asthmatics and
controls in the two studies.
In agreement with the current study results, no associ-
ation of the disease with GSTM1 null genotype was noted
by several studies in different populations [2,12-16,18].








n = 24 (%) n =36 (%) N = 34 (%)
GSTT1
Null 21 (87.5%) 29 (80.6%) 32 (94.1%)
Present 3 (12.5%) 7 (19.4%) 2 (5.9%) 0.236
GSTM1
Null 12 (50%) 19 (52.8%) 16 (47.1%)
Present 12 (50%) 17 (47.2%) 18 (52.9%) 0.892
ªData are expressed as no. (%) of patients unless otherwise indicated.this genotype in some reports [3,17,19-24]. The fact that
asthma pathogenesis is a result of interactions between
multiple genetic and environmental factors highlight that
exposure to environmental chemical agents may explain
the differences encountered.
A recent study done in Italy for asthmatic adults-
which revealed no association for both null genotypes
with the disease- stated that the differences in the preva-
lence of asthma in different ethnic groups reflect and
highlight genetic variances with a significant coverage of
environmental conditions. The study declared that rapid
change in asthma prevalence is not linked to genetic
changes in populations because these mechanisms are
too slow to explain this scenario and the effect of envir-
onmental exposures and interactions between genetic
factors and environmental conditions are still a matter
of debate [26].
The current study revealed that the frequencies of
GSTT1 and GSTM1 null genotypes in controls were
97.8% and 60.1% respectively. The frequencies previously
reported in the Egyptian population (15% and 44% re-
spectively among 34 subjects) [27] and in another study
a higher frequencies was reported (25.50% and 55.50%
respectively) [28]. According to our results, the fre-
quency of the GSTM1 null genotype (60.1%) was slightly
higher than the previous Egyptian studies, comparable
to Caucasians (50.4% -58%), Europeans (39.00–62.00%)
and White Americans (35.00–62.00%). However, the fre-
quency of the GSTT1 null genotype (97.8%) was extremely
higher than the range of the previous Egyptian studies,
Europeans (10.00–21.00%), Africans (15.00–26.00%) and
Caucasian- Americans (10.00–36.00%).
Differences in gene frequencies among various ethnic
groups, may explain the differences encountered. A pre-
vious study that attempted to investigate the prevalence
of important allelic variants of several genes including
GST gene in the Egyptian population denoted that Egypt
is unique geographically, as it is located centrally to the
three continents of Africa, Europe and Asia, so its popu-
lation is highly affected by the rapid pace of intercontin-
ental transportation and large-scale immigration and that
throughout history, the Greeks, Romans, Arabs, Turks,
French and British have all ruled Egypt and mixed with its
people, so that modern Egypt now is an amalgam of all
these legacies. So, there is a considerable genetic admix-
ture in the Egyptian population [28]. This genetic admix-
ture explains more the differences encountered between
the results of the current study done in Cairo- central
Egypt- and that performed in Zagazig- northern Egypt.
The present study compared the GSTT1and GSTM1
null genotypes among asthmatic patients with the levels
of asthma severity whether mild (87.5% and 50% re-
spectively), moderate (80.6% and 52.8% respectively) or
severe persistent (94.1% and 47.1% respectively) and it
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0.892 respectively). These findings were supported by
several studies [12,14,15,29,30].
Regarding the genetic polymorphisms of GSTT1 and
GSTM1 among atopic asthmatic patients and non-atopic
asthmatics, no significant statistical difference in GSTT1
and GSTM1 polymorphisms was noted between the two
groups (P value: 0.706 and 0.820 respectively). In agree-
ment with the current study, a study done on Egyptian
population in zagazig announced that there is no signifi-
cant association found between atopy and GSTT1 poly-
morphism. However, they found that the GSTM1 null
genotype was significantly higher in atopic asthmatic cases
than in nonatopic asthmatic subjects (P = 0.01) [25].
Comparison of our results with other studies indicates
that GSTT1 and GSTM1 null genotypes were not univer-
sally associated with the asthma phenotypes. The genetic
basis of asthma may differ between different ethnic groups.
Future studies of large size should focus on interactions of
GST genes with environmental oxidative exposures and
with other genes involved in antioxidant pathways. Quality
of study conduct and reporting need to be improved to in-
crease credibility of the evidence accumulating over time.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
NMR, NMD and MMW - Designed, conducted and analyzed the study, NAM
and NMR - Analyzed the data and drafted the manuscript. All authors revised
and approved the manuscript.
Funding
The study was self-funded by authors.
Author details
1Department of Pediatrics, Faculty of Medicine, Cairo University, Giza, Egypt.
2Department of Clinical Pathology, Faculty of Medicine, Cairo University, Giza,
Egypt. 3New University Children’s Hospital (Abu El Reish), 4 – Gamal Salem
St. Doki, Cairo, Egypt.
Received: 6 September 2013 Accepted: 19 February 2014
Published: 21 February 2014
References
1. Lemanske RF, Busse WW: Asthma: clinical expression and molecular
mechanisms. J Allergy Clin Immunol 2010, 125:95–102.
2. Holla LI, Stejskalova A, Vasku A: Polymorphisms of the GSTM1 and GSTT1
genes in patients with allergic diseases in the Czech population. Allergy
2006, 61(2):265–267.
3. Hanene C, Jihene L, Jamel A, Kamel H, Agnès H: Association of GST genes
polymorphisms with asthma in Tunisian children. Mediators Inflamm 2007,
37:1150–1157.
4. Goodrich GG, Goodman PH, Budhecha SK, Pritsos CA: Functional
polymorphism of detoxifi cation gene NQO1 predicts intensity of
empirical treatment of childhood asthma. Mutat Res 2009, 674:55–61.
5. Hayes JD, Flanagan JU, Jowsey IR: Glutathione transferases. Annu Rev
Pharmacol Toxicol 2005, 45:51–88.
6. Hayes JD, Strange RC: Potential contribution of the glutathione
S-transferase supergene family to resistance to oxidative stress.
Free Radic Res 1995, 22:193–197.
7. Reddy P, Naidoo RN, Robins TG, Mentz G, London SJ, Li H, Naidoo R:
GSTM1, GSTP1, and NQO1 polymorphisms and susceptibility to atopyand airway hyperresponsiveness among South African schoolchildren.
Lung 2010, 188:409–414.
8. Global Strategy for the Diagnosis and Management of Asthma, Global
Initiative for Asthma (GINA), revised 2010. http://www.ginasthma.com.
9. Sheikhha MH, Kalantar M, Tobal K, John A, Yin L: Glutathione S-transferase
null genotype in acute myeloid leukemia. IJI. 2005, 2:141–151.
10. Gilliland FD, Gauderman WJ, Vora H, Rappaport E, Dubeau L: Effects of
glutathione-S-transferase M1, T1, and P1 on childhood lung function
growth. AM J Respir Crit Care Med 2002, 166(5):710–716.
11. Minelli C, Granell R, Newson R, Rose-Zerilli M, Torrent M, Ring S,
Holloway JW, Shaheen SO, Henderson JA: Glutathione-S-transferase genes
and asthma phenotypes: a Human Genome Epidemiology (HuGE)
systematic review and meta-analysis including unpublished data. Int J
Epidemiol 2010, 39:539–562.
12. Freĭdin MB, Bragina EI, Ogorodova LM, Puzyrev VP: Polymorphism of the
theta1 and mu1 glutathione S-transferase genes (GSTT1, GSTM1) in
patients with atopic bronchial asthma from the West Siberian region.
Mol Biol 2002, 36(4):630–634.
13. Ercan H, Birben E, Dizdar EA, Keskin O, Karaaslan C, Soyer OU, Dut R,
Sackesen C, Besler T, Kalaysi O: Oxidative stress and genetic and
epidemiologic determinants of oxidants injury in childhood asthma.
J Allergy Clin Immunol 2006, 118:1097–1104.
14. Mak JC, Ho SP, Leung HC, Cheung AH, Law BK, So LK, Chan JW, Chao CH,
Lam WK, Ip MS, Chan-Yeung M: Relationship between glutathione
s-transferase gene polymorphisms and enzyme activity in Hong Kong
Chinese asthmatics. Clin Exp Allergy 2007, 37(8):1150–1157.
15. Salam MT, Lin PC, Avol EL, Gauderman WJ, Gilliland FD: Microsomal
epoxide hydrolasem glutathione Stransferase P1, traffic and childhood
asthma. Thorax 2007, 62(12):1050–1057.
16. Imboden M, Rochat T, Brutsche MH, Schindler C, Downs SH, Gerbase MW,
Burger W, Probst- Hensch NM, SAPALDIA Tea, APALDIA Team: Glutathione
S-transferase genotype increases risk progression from bronchial
hyperresponsiveness to asthma in adults. Thorax 2008, 63(4):322–328.
17. Islam T, Berhane K, McConnell R, Gauderman WJ, Avol E, Peters JM, Gilliland FD:
Glutathione-S-transferase (GST) P1, GSTM1, exercise, ozone and asthma
incidence in school children. Thorax 2009, 64(3):197–202.
18. Castro-Giner F, Künzli N, Jacquemin B, Forsberg B, de Cid R, Sunyer J,
Deborah J, David B, Danielle V, Dan N, González JR, Stefano G, Christer J,
Josep-Maria A, Matthias W, Joachim H, Xavier E, Manolis K: Traffic-related
air pollution, oxidative stress genes, and asthma (ECHRS). Environ Health
Perspect 2009, 117:1919–1924.
19. Rogers AJ, Brasch-Andersen C, Ionita-Laza I, Murphy A, Sharma S,
Klanderman BJ, Raby BA: The interaction of glutathione S-transferase
M1-null variants with tobacco smoke exposure and the development of
childhood asthma. Clin Exp Allergy 2009, 39:1721–1729.
20. Lima CS, Néri IA, Lourenço GJ, Faria IC, Ribeiro JD, Bertuzzo CS: Glutathione
S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) genetic polymorphisms
and atopic asthma in children from Southeastern Brazil. Genet Mol Biol
2010, 33:438–441.
21. Ivaschenko TE, Sideleva OG, Baranov VS: Glutathione-S-transferase μ and
theta gene polymorphisms as new risk factors of atopic bronchial
asthma. J Mol Medic 2002, 80(1):39–43.
22. Brasch-Andersen C, Christiansen L, Tan Q, Haagerup A, Vestbo J, Kruse TA:
Possible gene dosage effect of glutathione-S-transferases on atopic
asthma: using real-time PCR for quantification of GSTM1 and GSTT1
gene copy numbers. Hum Mutat 2004, 24(3):208–214.
23. Saadat M, Saadat I, Saboori Z, Emad A: Combination of CC16, and GSTT1
genetic polymorphism is associated with asthma. J Allergy Clin Immunol
2006, 113:996–998.
24. Tamer L, MC a g, Ates NA, Yildirim H, Ercan B, Saritas E, Unlu A, Atik U:
Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1,
GSTP1) as increased risk factors for asthma. Respirology 2004,
9(4):493–498.
25. Karam RA, Pasha HF, El-Shal AS, Rahman HM, Gad DM: Impact of
glutathione-S-transferase gene polymorphisms on enzyme activity, lung
function and bronchial asthma susceptibility in Egyptian children. Gene
2012, 497:314–319.
26. Piacentini S, Polimanti R, Moscatelli B, RE M, Manfellotto D, Fuciarelli M: Lack
of association between GSTM1, GSTP1, and GSTT1 gene polymorphisms
and asthma in adult patients from Rome, Central Italy. J Investig Allergol
Clin Immunol 2012, 22(4):252–256.
El Rifai et al. Italian Journal of Pediatrics 2014, 40:22 Page 6 of 6
http://www.ijponline.net/content/40/1/2227. Abdel-Rahman SZ, El-Zein RA, Anwar WA, Au WW: A multiplex PCR proced-
ure for polymorphic analysis of GSTM1 and GSTT1 genes in population
studies. Cancer Lett 1996, 107:229–233.
28. Hamdy SI, Hiratsuka M, Narahara K, Endo N, El Enani M, Moursi N: Genotype
and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR- 1 in the
Egyptian population. J Clin Pharmacol 2003, 55(6):560–569.
29. Sandford J, Chan HW, Wong GMK, Lai CKW, Chan-Yeung M: Candidate
genetic polymorphisms for asthma in Chinese schoolchildren from
Hong Kong. Intern J Tuberc Lung Dis 2004, 8(5):519–527.
30. Gattás GJ, Kato M, Soares-Vieira JA, Siraque MS, Kohler P, Gomes L, Rigo MA,
Bydlowski SP: Ethnicity and glutathione S-transferase (GSTM1/GSTT1)
polymorphisms in a Brazilian population. Braz J Med Biol Res 2004,
37:451–458.
doi:10.1186/1824-7288-40-22
Cite this article as: El Rifai et al.: Glutathione S transferase theta1 and
mu1 gene polymorphisms and phenotypic expression of asthma in
Egyptian children: a case–control study. Italian Journal of Pediatrics
2014 40:22.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
